These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 18262039)
1. Effect of aprotinin on renal dysfunction in patients undergoing on-pump and off-pump cardiac surgery: a retrospective observational study. Mouton R; Finch D; Davies I; Binks A; Zacharowski K Lancet; 2008 Feb; 371(9611):475-82. PubMed ID: 18262039 [TBL] [Abstract][Full Text] [Related]
2. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery? Kincaid EH; Ashburn DA; Hoyle JR; Reichert MG; Hammon JW; Kon ND Ann Thorac Surg; 2005 Oct; 80(4):1388-93; discussion 1393. PubMed ID: 16181876 [TBL] [Abstract][Full Text] [Related]
3. Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL. Wagener G; Gubitosa G; Wang S; Borregaard N; Kim M; Lee HT Am J Nephrol; 2008; 28(4):576-82. PubMed ID: 18264006 [TBL] [Abstract][Full Text] [Related]
4. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo). Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959 [TBL] [Abstract][Full Text] [Related]
5. Coronary artery bypass grafting after aprotinin: are we doing better? Beckerman Z; Shopen Y; Alon H; Cohen O; Nir RR; Adler Z; Bolotin G J Thorac Cardiovasc Surg; 2013 Jan; 145(1):243-8. PubMed ID: 23072702 [TBL] [Abstract][Full Text] [Related]
9. The risk associated with aprotinin in cardiac surgery. Mangano DT; Tudor IC; Dietzel C; ; N Engl J Med; 2006 Jan; 354(4):353-65. PubMed ID: 16436767 [TBL] [Abstract][Full Text] [Related]
10. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting. Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562 [TBL] [Abstract][Full Text] [Related]
11. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. Karkouti K; Wijeysundera DN; Yau TM; McCluskey SA; Tait G; Beattie WS Anesth Analg; 2010 Jan; 110(1):21-9. PubMed ID: 19910626 [TBL] [Abstract][Full Text] [Related]
12. [Control of postoperative hemorrhage in isolated coronary bypass surgery: comparison of tranexamic acid effects in off-pump surgery with aprotinin effects in conventional surgery]. Bordalo AD; Nobre AL; Silva F; Serpa C; Cravino J Rev Port Cir Cardiotorac Vasc; 2011; 18(3):143-8. PubMed ID: 23596616 [TBL] [Abstract][Full Text] [Related]
13. The effect of aprotinin on outcome after coronary-artery bypass grafting. Shaw AD; Stafford-Smith M; White WD; Phillips-Bute B; Swaminathan M; Milano C; Welsby IJ; Aronson S; Mathew JP; Peterson ED; Newman MF N Engl J Med; 2008 Feb; 358(8):784-93. PubMed ID: 18287601 [TBL] [Abstract][Full Text] [Related]
17. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass. Manrique A; Jooste EH; Kuch BA; Lichtenstein SE; Morell V; Munoz R; Ellis D; Davis PJ Anesth Analg; 2009 Jul; 109(1):45-52. PubMed ID: 19535694 [TBL] [Abstract][Full Text] [Related]
18. The risks associated with aprotinin use: a retrospective study of cardiac cases in Nova Scotia. Riddell RE; Buth KJ; Sullivan JA Can J Anaesth; 2013 Jan; 60(1):16-23. PubMed ID: 23132043 [TBL] [Abstract][Full Text] [Related]
20. Aprotinin and the risk of death and renal dysfunction in patients undergoing cardiac surgery: a meta-analysis of epidemiologic studies. Gagne JJ; Griesdale DE; Schneeweiss S Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):259-68. PubMed ID: 19185048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]